[18F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)
Purpose. Quantitative in vivo [18F]-(2S,4R)4-fluoroglutamine ([18F]4-FGln or more simply [18F]FGln) metabolic kinetic parameters are compared with activity levels of glutamine metabolism in different types of hepatocellular carcinoma (HCC). Methods. For this study, we used two transgenic mouse model...
Saved in:
| Main Authors: | Youngho Seo, Miranda C. Craig, Stephanie T. Murphy, Jinjin Feng, Xin Chen, Mariia Yuneva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-01-01
|
| Series: | Molecular Imaging |
| Online Access: | http://dx.doi.org/10.1155/2022/5185951 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deuterium- and Fluorine-18-Labeled Glutaminea PET Imaging Agent with Enhanced In Vivo Stability
by: Hari K. Akula, et al.
Published: (2025-07-01) -
An Evidence-Based Multidisciplinary Approach to the Management of Hepatocellular Carcinoma (HCC): The Alberta HCC Algorithm
by: Kelly W Burak, et al.
Published: (2010-01-01) -
Imaging Hepatocellular Carcinoma With Ga-Citrate PET: First Clinical Experience
by: Carina Mari Aparici MD, et al.
Published: (2017-09-01) -
[18F]FDG/PET: a non-invasive technique for the study of stroke in murine and rat models
by: B. G. A. Schirmer, et al.
Published: (2023-04-01) -
Exposure of Bisphenols (BPs) to hepatocellular carcinoma (HCC) patients and non-HCC patients: Association with liver function biomarkers
by: Shibo Li, et al.
Published: (2024-12-01)